NM_002544.5:c.62G>A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_002544.5(OMG):​c.62G>A​(p.Gly21Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.114 in 1,613,850 control chromosomes in the GnomAD database, including 12,075 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: 𝑓 0.081 ( 686 hom., cov: 32)
Exomes 𝑓: 0.12 ( 11389 hom. )

Consequence

OMG
NM_002544.5 missense

Scores

2
16

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: 1.45

Publications

43 publications found
Variant links:
Genes affected
OMG (HGNC:8135): (oligodendrocyte myelin glycoprotein) Predicted to enable identical protein binding activity. Predicted to be involved in neuron projection regeneration. Predicted to act upstream of or within regulation of collateral sprouting of intact axon in response to injury. Predicted to be located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
NF1 (HGNC:7765): (neurofibromin 1) This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA>UGA->Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. [provided by RefSeq, Jul 2008]
NF1 Gene-Disease associations (from GenCC):
  • neurofibromatosis type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae)
  • neurofibromatosis-Noonan syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • Moyamoya disease
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial ovarian cancer
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_002544.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0014791489).
BP6
Variant 17-31296270-C-T is Benign according to our data. Variant chr17-31296270-C-T is described in ClinVar as Benign. ClinVar VariationId is 3055468.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.123 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002544.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OMG
NM_002544.5
MANE Select
c.62G>Ap.Gly21Asp
missense
Exon 2 of 2NP_002535.3
NF1
NM_001042492.3
MANE Select
c.4836-29550C>T
intron
N/ANP_001035957.1P21359-1
NF1
NM_000267.4
c.4773-29550C>T
intron
N/ANP_000258.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OMG
ENST00000247271.5
TSL:1 MANE Select
c.62G>Ap.Gly21Asp
missense
Exon 2 of 2ENSP00000247271.4P23515
NF1
ENST00000358273.9
TSL:1 MANE Select
c.4836-29550C>T
intron
N/AENSP00000351015.4P21359-1
NF1
ENST00000356175.7
TSL:1
c.4773-29550C>T
intron
N/AENSP00000348498.3P21359-2

Frequencies

GnomAD3 genomes
AF:
0.0812
AC:
12354
AN:
152084
Hom.:
686
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0246
Gnomad AMI
AF:
0.0943
Gnomad AMR
AF:
0.0767
Gnomad ASJ
AF:
0.0655
Gnomad EAS
AF:
0.000576
Gnomad SAS
AF:
0.0414
Gnomad FIN
AF:
0.0943
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.125
Gnomad OTH
AF:
0.0708
GnomAD2 exomes
AF:
0.0912
AC:
22893
AN:
251078
AF XY:
0.0909
show subpopulations
Gnomad AFR exome
AF:
0.0238
Gnomad AMR exome
AF:
0.0821
Gnomad ASJ exome
AF:
0.0660
Gnomad EAS exome
AF:
0.000925
Gnomad FIN exome
AF:
0.100
Gnomad NFE exome
AF:
0.132
Gnomad OTH exome
AF:
0.0875
GnomAD4 exome
AF:
0.118
AC:
172364
AN:
1461648
Hom.:
11389
Cov.:
32
AF XY:
0.115
AC XY:
83976
AN XY:
727156
show subpopulations
African (AFR)
AF:
0.0207
AC:
694
AN:
33474
American (AMR)
AF:
0.0811
AC:
3628
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0676
AC:
1767
AN:
26132
East Asian (EAS)
AF:
0.000630
AC:
25
AN:
39692
South Asian (SAS)
AF:
0.0428
AC:
3691
AN:
86252
European-Finnish (FIN)
AF:
0.105
AC:
5623
AN:
53414
Middle Eastern (MID)
AF:
0.0392
AC:
226
AN:
5768
European-Non Finnish (NFE)
AF:
0.136
AC:
150739
AN:
1111812
Other (OTH)
AF:
0.0989
AC:
5971
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
7978
15956
23933
31911
39889
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5278
10556
15834
21112
26390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0812
AC:
12352
AN:
152202
Hom.:
686
Cov.:
32
AF XY:
0.0803
AC XY:
5974
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.0245
AC:
1020
AN:
41548
American (AMR)
AF:
0.0766
AC:
1171
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.0655
AC:
227
AN:
3466
East Asian (EAS)
AF:
0.000578
AC:
3
AN:
5192
South Asian (SAS)
AF:
0.0415
AC:
200
AN:
4824
European-Finnish (FIN)
AF:
0.0943
AC:
998
AN:
10584
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.125
AC:
8488
AN:
67992
Other (OTH)
AF:
0.0696
AC:
147
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
574
1149
1723
2298
2872
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
146
292
438
584
730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.107
Hom.:
3405
Bravo
AF:
0.0775
Asia WGS
AF:
0.0160
AC:
61
AN:
3478
EpiCase
AF:
0.114
EpiControl
AF:
0.118

ClinVar

ClinVar submissions
Significance:Benign
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
OMG-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
22
DANN
Benign
0.96
DEOGEN2
Benign
0.063
T
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.085
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Benign
0.72
T
MetaRNN
Benign
0.0015
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.55
N
PhyloP100
1.4
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-0.69
N
REVEL
Benign
0.035
Sift
Uncertain
0.0030
D
Sift4G
Benign
0.42
T
Varity_R
0.14
gMVP
0.37
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs11080149;
hg19: chr17-29623288;
COSMIC: COSV55988007;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.